These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 16494581

  • 1. Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis.
    Oh BK, Kim YJ, Park YN, Choi J, Kim KS, Park C.
    Am J Gastroenterol; 2006 Apr; 101(4):831-8. PubMed ID: 16494581
    [Abstract] [Full Text] [Related]

  • 2. Telomerase activation in human hepatocarcinogenesis.
    Hytiroglou P, Theise ND.
    Am J Gastroenterol; 2006 Apr; 101(4):839-41. PubMed ID: 16635228
    [Abstract] [Full Text] [Related]

  • 3. Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma.
    Toshikuni N, Nouso K, Higashi T, Nakatsukasa H, Onishi T, Kaneyoshi T, Kobayashi Y, Kariyama K, Yamamoto K, Tsuji T.
    Br J Cancer; 2000 Feb; 82(4):833-7. PubMed ID: 10732755
    [Abstract] [Full Text] [Related]

  • 4. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression.
    Chen CJ, Tsai NM, Liu YC, Ho LI, Hsieh HF, Yen CY, Harn HJ.
    Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954
    [Abstract] [Full Text] [Related]

  • 5. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis.
    Satra M, Gatselis N, Iliopoulos D, Zacharoulis D, Dalekos GN, Tsezou A.
    J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
    Saini N, Srinivasan R, Chawla Y, Sharma S, Chakraborti A, Rajwanshi A.
    Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
    [Abstract] [Full Text] [Related]

  • 8. hTERT expression in sporadic renal cell carcinomas.
    Paradis V, Bièche I, Dargère D, Bonvoust F, Ferlicot S, Olivi M, Lagha NB, Blanchet P, Benoît G, Vidaud M, Bedossa P.
    J Pathol; 2001 Sep; 195(2):209-17. PubMed ID: 11592100
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma.
    Takuma Y, Nouso K, Kobayashi Y, Nakamura S, Tanaka H, Matsumoto E, Fujikawa T, Suzuki M, Hanafusa T, Shiratori Y.
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1300-4. PubMed ID: 15482538
    [Abstract] [Full Text] [Related]

  • 12. [Expression of telomerase reverse transcriptase and its relationship with tumor suppressor gene p53 in HCC].
    Dai D, Zhai W, Zhu T, Zhu H, Ling Y.
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():79-81. PubMed ID: 11509149
    [Abstract] [Full Text] [Related]

  • 13. Human telomerase reverse transcriptase expression and its clinical significance in laryngeal squamous cell carcinoma.
    Li YR, Wu JM, Wang L, Huang X, Shi J, Hu LH.
    Acta Otolaryngol; 2005 Apr; 125(4):409-14. PubMed ID: 15823813
    [Abstract] [Full Text] [Related]

  • 14. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
    Takihana Y, Tsuchida T, Fukasawa M, Araki I, Tanabe N, Takeda M.
    Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
    [Abstract] [Full Text] [Related]

  • 15. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.
    Miura N, Maeda Y, Kanbe T, Yazama H, Takeda Y, Sato R, Tsukamoto T, Sato E, Marumoto A, Harada T, Sano A, Kishimoto Y, Hirooka Y, Murawaki Y, Hasegawa J, Shiota G.
    Clin Cancer Res; 2005 May 01; 11(9):3205-9. PubMed ID: 15867214
    [Abstract] [Full Text] [Related]

  • 16. Telomerase reverse transcriptase mRNA expression in peripheral lymphocytes of patients with chronic HBV and HCV infections.
    Satra M, Dalekos GN, Kollia P, Vamvakopoulos N, Tsezou A.
    J Viral Hepat; 2005 Sep 01; 12(5):488-93. PubMed ID: 16108763
    [Abstract] [Full Text] [Related]

  • 17. Telomerase activity in precancerous hepatic nodules.
    Hytiroglou P, Kotoula V, Thung SN, Tsokos M, Fiel MI, Papadimitriou CS.
    Cancer; 1998 May 15; 82(10):1831-8. PubMed ID: 9587114
    [Abstract] [Full Text] [Related]

  • 18. [Relationship among telomerase activity, expression of human telomerase reverse transcriptase (hTERT), and expression of c-myc in acute leukemia].
    Cheng X, Chen ZX, Wang W, Fu JX, Cen JN, Yao L.
    Ai Zheng; 2003 Nov 15; 22(11):1175-9. PubMed ID: 14613647
    [Abstract] [Full Text] [Related]

  • 19. Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta.
    Park YN, Chae KJ, Oh BK, Choi J, Choi KS, Park C.
    Hepatogastroenterology; 2004 Nov 15; 51(56):396-400. PubMed ID: 15086168
    [Abstract] [Full Text] [Related]

  • 20. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM, Larson AM, Campbell JS, Fausto N, Rulyak SJ, Swanson PE.
    Am J Surg Pathol; 2007 May 15; 31(5):681-9. PubMed ID: 17460450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.